ASCO: 2013 GI Cancers Symposium Preliminary Program Agenda
For CELGZ this is the event we're all waiting for. I expect CELG to issue a press release before the formal presentation that shows the increase in overall survival it has been touting. Winning the war on cancer---especially pancreatic, where nothing else has worked until now, is huge---Go CELGZ!
Abraxane: Friday January 25:2:00 PM — 3:30 PM
ABSTRACT LBA #148: Final results of a randomized phase III study of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas.
Daniel D. Von Hoff, MD